Clinical trial

N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus Chemoradiation

NCT02966769

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Overall survival Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus Chemoradiation

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2016-06-01

PhaseN/A

Conditions

Non-small-Cell Lung Carcinomaunresolved

Surgeryunresolved

Stage IIIA-N2unresolved

Chemoradiationunresolved

Survivalunresolved

Interventions

Overall survivalOTHER

Sponsors & collaborators

Grupo de Investigación Clínica en Oncología Radioterapialead sponsor

Mapped research locations

MadridSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02966769 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.